Salt Lake City, Utah, USA – At the International Society for Magnetic Resonance in Medicine’s (ISMRM) 21^st Annual Meeting & Exhibition in Salt Lake City, Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today demonstrated a range of clinical functionalities in Magnetic Resonance Imaging (MRI)*, raising the bar on clinical excellence through greater collaboration, integration and increased patient focus.

An increasing global incidence of neuro and vascular disease across the world is a result of both aging populations and increasingly unhealthy lifestyles¹. Philips is working in close collaboration with clinicians and researchers from across the world to develop new clinical functionalities that support high quality, clinically relevant diagnostics, whilst also improving patient throughput.

“Increasingly, MRI is proving its worth as a quick and cost effective diagnostic tool for the management of a wide variety of conditions; from stroke and dementia to tumor disease and trauma,” commented Dr. Jeroen Hendrikse, University Medical Center Utrecht, Department of Radiology. “A great example of this is pCASL, a functionality we’ve developed in close collaboration with the team at Philips. Not only does pCASL provide the user with an accurate assessment of brain perfusion - without the need for external contrast agent, a contraindication for many patients with renal insufficiency - but it’s also quick, taking just a short amount of additional time to scan.”

Dr. Jeffrey Miller, MD, Pediatric Neuroradiologist, Phoenix Children’s Hospital, Arizona, adds, “Having access to these functionalities (pCASL, SWIp, mDIXON TSE and mDIXON Quant) means that we’re able to detect injuries that may not be apparent using conventional techniques, which can ultimately mean a better outcome for our patients. In particular, we’re seeing a real benefit from the image quality provided by the time-efficient mDIXON TSE technique in challenging anatomies such as spine, as well as the lesion delineation it provides.”

The functionalities*, developed collaboratively, that are being showcased at ISMRM include:

The development of these latest functionalities is a direct result of the ongoing clinical collaborations which Philips has in-place with leading clinicians and researchers, including with Dr. Hendrikse in Utrecht and Dr. Miller in Phoenix.

“As we continue to expand our MRI portfolio at Philips, our focus is to provide solutions that address the day-to-day needs of the radiology and clinical teams. Ultimately, innovation is only meaningful if it can bring about positive change for patients. Our commitment to achieving this is evident through our many and ongoing research collaborations,” commented Eric Jean, General Manager Global MR, Philips Healthcare. “It really is exciting to see that this approach is instrumental in addressing some of the most significant challenges in MRI today.”

* New functionalities available now on Philips Ingenia system, and on all Philips MRI systems by end of 2013

** 510(k) pending. Not available for sale in USA

Visit Philips at ISMRM 2013 at booth #274 or online via www.philips.com/ismrm.

References
1. World Heart Federation. Urbanization and cardiovascular disease. www.world-heart-federation.org/press/fact-sheets/urbanization-and-cardiovascular-disease/.